Macrogenics (MGNX)
3.63
+0.04 (1.11%)
Upcoming Events
Latest Headlines
Form 144 MACROGENICS INC Filed by: Ferrante Karen Jean
October 22, 2026 4:17 PM - SEC Filing
MacroGenics doses first patient in Phase 1 trial of MGC030 ADC
October 15, 2026 4:05 PM - StreetInsider
MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors
October 15, 2026 4:05 PM - StreetInsider
Form 4 MACROGENICS INC For: Oct 06 Filed by: Bonvini Ezio
October 7, 2026 4:23 PM - SEC Filing
Form 144 MACROGENICS INC Filed by: Spitznagel Thomas
September 21, 2026 4:11 PM - SEC Filing
MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 9, 2026 4:05 PM - StreetInsider
Form 4 MACROGENICS INC For: Aug 19 Filed by: Peters Jeffrey Stuart
August 20, 2026 6:19 PM - SEC Filing
Form 144 MACROGENICS INC Filed by: Peters Jeffrey Stuart
August 19, 2026 5:20 PM - SEC Filing
Form 4 MACROGENICS INC For: Aug 17 Filed by: Bonvini Ezio
August 18, 2026 4:19 PM - SEC Filing
Form 144 MACROGENICS INC Filed by: SIEGEL JAY PHILIP
August 17, 2026 5:37 PM - SEC Filing
MacroGenics (MGNX) PT Raised to $11 at B.Riley
August 17, 2026 9:09 AM - StreetInsider
Form 10-Q MACROGENICS INC For: Jun 30
August 14, 2026 4:27 PM - SEC Filing
Form SCHEDULE 13G/A MACROGENICS INC Filed by: ARMISTICE CAPITAL, LLC
August 14, 2026 10:22 AM - SEC Filing
Macrogenics (MGNX) Misses Q2 EPS by 102c
August 13, 2026 4:23 PM - StreetInsider
Form 8-K MACROGENICS INC For: Aug 13
August 13, 2026 4:10 PM - SEC Filing
MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position
August 13, 2026 4:06 PM - Globe NewsWire
Gilead exercises option on MacroGenics bispecific program, triggering $10M
August 11, 2026 4:05 PM - StreetInsider
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
August 11, 2026 4:05 PM - StreetInsider
Form 144 MACROGENICS INC Filed by: SIEGEL JAY PHILIP
August 3, 2026 4:31 PM - SEC Filing
Form SCHEDULE 13G/A MACROGENICS INC Filed by: BANK OF AMERICA CORP /DE/
August 3, 2026 4:18 PM - SEC Filing
Form SCHEDULE 13G MACROGENICS INC Filed by: BlackRock, Inc.
July 29, 2026 3:21 PM - SEC Filing
MacroGenics (MGNX) Reiterated at Market Perform by Citizens Ahead of ESMO '26 Data
July 27, 2026 5:24 AM - StreetInsider
Full Article List
